OTCMKTS:KHRNF

Khiron Life Sciences (KHRNF) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
$0.0001
$0.0175
52-Week Range
N/A
Volume
N/A
Average Volume
171,788 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
KHRNF stock logo

About Khiron Life Sciences Stock (OTCMKTS:KHRNF)

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

KHRNF Stock News Headlines

Khiron Life Sciences Corp.
Khiron Life Sciences Corp. (KHRNF)
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
Khiron Life Sciences Corp (4KH.BE)
KHRNF - Khiron Life Sciences Corp.
Biden to Launch “FedNOW” [Move Your Money Now]
Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentially cancel your money. You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar...
KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER
Khiron Completes First Phase of Business Optimization
KHIRON LIFE SCIENCES ANNOUNCES NEW CFO
KHRNF Khiron Life Sciences Corp.
Khiron Closes Additional Loan with Investment-Grade Bank
See More Headlines
Receive KHRNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:KHRNF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Alvaro Francisco Torres (Age 45)
    Co-Founder, CEO & Director
    Comp: $200.96k
  • Ms. Franziska Katterbach
    President of Khiron Europe
  • Mr. Swapan Kakumanu ACA (Age 54)
    ACWA, CGA, Corporate Secretary
    Comp: $44.18k
  • Mr. Michael John O'Connor MA (Age 57)
    Chief Financial Officer
  • Mr. Manuel Buendia
    Vice President of Operations
  • Mr. Marco Algorta
    Country Manager of Uruguay

KHRNF Stock Analysis - Frequently Asked Questions

How do I buy shares of Khiron Life Sciences?

Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:KHRNF) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners